A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/18/2011	WO2011040954A9 Tp53 gene expression and uses thereof
08/18/2011	WO2011035120A3 Therapeutic composition to treat lesions caused by herpes simplex virus
08/18/2011	WO2011029547A3 Pregnane derivatives condensed in the 16, 17 position with an n-substituted isoxazolidine ring as anti-inflammatory agents
08/18/2011	WO2011021938A3 Regulating the amino acid pool used for the acute-phase protein synthesis
08/18/2011	WO2011019636A3 Methods and compositions for the treatment of cancers and pathogenic infections
08/18/2011	WO2010151797A3 Compounds for modulating rna binding proteins and uses therefor
08/18/2011	WO2010144865A9 Methods for treating gastrointestinal disorders
08/18/2011	WO2010124198A3 Agglomerate formulations useful in dry powder inhalers
08/18/2011	WO2010084041A3 Pharmaceutical compositions comprising a hcv polymerase inhibitor prodrug
08/18/2011	WO2010068181A8 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt
08/18/2011	WO2010066253A8 Selective inhibitors of excitatory amino acid transporter subtype 1 (eaat1 /glast)
08/18/2011	WO2010057710A9 Process for the purification of heparan sulfate and use thereof in cosmetological and dermatological preparations
08/18/2011	US20110203007 Assays of neurodegenerative disorders, including frontotemporal dementia and amyotrophic lateral sclerosis
08/18/2011	US20110202033 Compositions and methods for the treatment and prevention of cardiac ischemic injury
08/18/2011	US20110202025 Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis
08/18/2011	US20110201926 Local embolization via heating of thermosensitive polymers
08/18/2011	US20110201817 Levodopa prodrugs, and compositions and uses thereof
08/18/2011	US20110201694 Compositions and Methods for Treatment of Disorders of Protein Aggregation
08/18/2011	US20110201693 Hydroalcoholic antimicrobial composition with skin health benefits
08/18/2011	US20110201692 Antimicrobial flush solutions
08/18/2011	US20110201691 Modulation of fibroblast activity
08/18/2011	US20110201690 Deuterium-enriched dapoxetine
08/18/2011	US20110201689 Compositions containing quaternary ammonium compounds
08/18/2011	US20110201688 N,n'-di-p-bromophenyl guanidine treatment for stroke at delayed timepoints
08/18/2011	US20110201687 Amide derivative, pest control agent containing the amide derivative, and use of the amide derivative
08/18/2011	US20110201686 Inhibitors of ASS and Synuclein Aggregation
08/18/2011	US20110201685 Compositions
08/18/2011	US20110201684 EP2 Agonist from Non-Prostanoid Structures Designed as PGE2 Antagonists
08/18/2011	US20110201683 Oil containing one or more long-chain polyunsaturated fatty acids phospholipids derived from biomass
08/18/2011	US20110201680 formulation of silymarin with high efficacy and prolonged action and the preparation method thereof
08/18/2011	US20110201679 Use of Tocotrienols for Elevating IKBKAP Gene Expression and Treating Neurodegenerative Diseases or Disorders
08/18/2011	US20110201678 Xanthenone-4-Acetic Acid Derivatives
08/18/2011	US20110201677 Promoters exhibiting endothelial cell specificity and methods of using same
08/18/2011	US20110201676 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides
08/18/2011	US20110201675 ON01910.Na ENHANCES CHEMOTHERAPEUTIC AGENT ACTIVITY IN DRUG-RESISTANT TUMORS
08/18/2011	US20110201674 Saporin-L1 inhibitors and uses thereof
08/18/2011	US20110201671 Compositions And Methods For Inhibiting Expression Of A Gene From The Ebola Virus
08/18/2011	US20110201670 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
08/18/2011	US20110201669 Methods and compositions for the diagnosis and treatment of cancer
08/18/2011	US20110201668 Regulation of neurotransmitter release through anion channels
08/18/2011	US20110201667 Compositions and methods for silencing ebola virus gene expression
08/18/2011	US20110201666 Compounds from mycelium of antrodia cinnamomea and use thereof
08/18/2011	US20110201665 Compositions, Methods, and Kits for Treating Influenza Viral Infections
08/18/2011	US20110201664 Methods and Compositions for Treatment of Prostate Intraepithelial Neoplasia
08/18/2011	US20110201663 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
08/18/2011	US20110201661 Spiro Derivatives of Parthenin as Novel Anticancer Agents
08/18/2011	US20110201659 Agent for preventing or treating zoster-associated pain
08/18/2011	US20110201658 Pharmaceutical package
08/18/2011	US20110201657 Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
08/18/2011	US20110201656 Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
08/18/2011	US20110201655 Pharmaceutical composition improving intestinal absorption
08/18/2011	US20110201654 Therapeutic combination
08/18/2011	US20110201653 Method for inhibiting and/or preventing formation of cancer metastases and secondary malignant cancer
08/18/2011	US20110201652 2,4-Disubstituted Pyrrolidine Orexin Receptor Antagonists
08/18/2011	US20110201651 Mitotic kinesin inhibitors and methods of use thereof
08/18/2011	US20110201650 Cyclohexane derivative and pharmaceutical use thereof
08/18/2011	US20110201648 Poly-heteroaryl derivatives for the treatment of cancer
08/18/2011	US20110201647 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase
08/18/2011	US20110201646 Optical isomers of an iloperidone metabolite
08/18/2011	US20110201645 Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate
08/18/2011	US20110201644 Crystalline form of a benzimidazole-carboxamide medicinal compound
08/18/2011	US20110201643 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds
08/18/2011	US20110201642 Bioactive Compounds
08/18/2011	US20110201641 Indole derivatives as crth2 receptor antagonists
08/18/2011	US20110201640 Tricyclic compound
08/18/2011	US20110201639 Stabilized tacrolimus composition
08/18/2011	US20110201638 PHENANTHROINDOLIZIDINE COMPOUND AND NFkB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
08/18/2011	US20110201637 Phenanthroindolizidine derivative and nfkb inhibitor containing same as active ingredient
08/18/2011	US20110201636 Use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment and/or prevention of serious depression and sleep/waking cycle disorders
08/18/2011	US20110201635 Substituted spiroindolinones
08/18/2011	US20110201634 Dihydropyridimidinone compounds for the treatment of cardiovascular diseases and process for preparing the same
08/18/2011	US20110201633 Alfuzosin tablets and synthesis
08/18/2011	US20110201632 2,5-Disubstituted Piperidine Orexin Rceptor Antagonists
08/18/2011	US20110201631 Pharmaceutical formulations comprising pemetrexed
08/18/2011	US20110201630 Fused Pyridine Derivatives as Kinase Inhibitors
08/18/2011	US20110201629 Cyclohexyl amide derivatives as crf receptor antagonists
08/18/2011	US20110201628 Heterocyclic jak kinase inhibitors
08/18/2011	US20110201627 Freeze-dried reparation of tetrodotoxin and the producing method thereof
08/18/2011	US20110201626 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
08/18/2011	US20110201625 Organic Comopunds
08/18/2011	US20110201624 Pharmaceutical Composition for Prevention and Treatment of Diabetes or Obesity Comprising a Compound that Inhibits Activity of Dipeptidyl Peptidase-IV, and other Antidiabetic or Antiobesity Agents as Active Ingredients
08/18/2011	US20110201623 Crystalline Form Of A Cyclopropyl Benzamide Derivative
08/18/2011	US20110201622 Solid Forms Comprising A Cyclopropyl Amide Derivative
08/18/2011	US20110201621 Angiotensin ii receptor antagonists
08/18/2011	US20110201620 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
08/18/2011	US20110201619 Use of N-Phenyl-2-pyrimidineamine Derivatives Against Mast Cell-based Diseases Like Allergic Disorders
08/18/2011	US20110201618 Kmups inhibiting proliferation and obliteration of pulmonary artery
08/18/2011	US20110201617 Therapeutic Uses Of Compounds Having Combined SERT, 5-HT3 And 5-HT1A Activity
08/18/2011	US20110201616 Sulfonamide compounds or salts thereof
08/18/2011	US20110201615 Triazole beta carboline derivatives as anti-diabetic agents
08/18/2011	US20110201614 Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals
08/18/2011	US20110201612 Compositions for Modulating a Kinase Cascade and Methods of Use Thereof
08/18/2011	US20110201611 Process for the Preparation of Compositions for Modulating a Kinase Cascade and Methods of Use Thereof
08/18/2011	US20110201610 Aryl sulfonamides
08/18/2011	US20110201609 Proteasome inhibitors for selectively inducing apoptosis in cancer cells
08/18/2011	US20110201608 Substituted naphthyridines and use thereof as medicines
08/18/2011	US20110201607 Fused heterocyclic m1 receptor positive allosteric modulators
08/18/2011	US20110201606 Pyrimidine derivatives
08/18/2011	US20110201605 Heteroaryl substituted piperidines
08/18/2011	US20110201604 Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof

1 ... 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 ... 7860